N-(2-chlorobenzyl)-3-(2-piperidin-1-ylpyrimidin-5-yl)benzamide结构式
|
常用名 | N-(2-chlorobenzyl)-3-(2-piperidin-1-ylpyrimidin-5-yl)benzamide | 英文名 | N-(2-chlorobenzyl)-3-(2-piperidin-1-ylpyrimidin-5-yl)benzamide |
|---|---|---|---|---|
| CAS号 | 1112339-32-8 | 分子量 | 368.7 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C18H10ClFN4O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(2-chlorobenzyl)-3-(2-piperidin-1-ylpyrimidin-5-yl)benzamide |
|---|
| 分子式 | C18H10ClFN4O2 |
|---|---|
| 分子量 | 368.7 |
| InChIKey | IYFGQXVGDKEPSK-UHFFFAOYSA-N |
| SMILES | O=c1ccn(-c2cccc(F)c2)nc1-c1nc(-c2cccc(Cl)c2)no1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|